US HV Bushing Market

ID: MRFR/EnP/15049-HCR 100 Pages Snehal Singh Last Updated: September 15, 2026
US HV Bushing Market Research Report By Type (Condenser Type, Non-Condenser Type), By Voltage Rating (15kV-170kV, 170kV-245kV, 245kV & Above), By Installation (Indoor, Outdoor) and By End-Use Industry (Industrial, Utilities, Others) - Forecast to 2035
US HV Bushing Market
Market Size
Forecast Period2025 - 2035
CAGR (2025 - 2035)2.68%
2024 Market Size$ 142.2 Million
2025 Market Size$ 146.01 Million
2035 Market Size$ 190.26 Million
Key Players
Siemens
General Electric
Schneider Electric
ABB
Mitsubishi Electric
Nexans
Opportunities
  • Aging Electrical Infrastructure
  • Rising Demand for Renewable Energy
  • Regulatory Compliance and Standards
  1. 1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
    1. 1.1 EXECUTIVE SUMMARY
      1. 1.1.1 Market Overview
      2. 1.1.2 Key Findings
      3. 1.1.3 Market Segmentation
      4. 1.1.4 Competitive Landscape
      5. 1.1.5 Challenges and Opportunities
      6. 1.1.6 Future Outlook
  2. 2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
    1. 2.1 MARKET INTRODUCTION
      1. 2.1.1 Definition
      2. 2.1.2 Scope of the study
        1. 2.1.2.1 Research Objective
        2. 2.1.2.2 Assumption
        3. 2.1.2.3 Limitations
    2. 2.2 RESEARCH METHODOLOGY
      1. 2.2.1 Overview
      2. 2.2.2 Data Mining
      3. 2.2.3 Secondary Research
      4. 2.2.4 Primary Research
        1. 2.2.4.1 Primary Interviews and Information Gathering Process
        2. 2.2.4.2 Breakdown of Primary Respondents
      5. 2.2.5 Forecasting Model
      6. 2.2.6 Market Size Estimation
        1. 2.2.6.1 Bottom-Up Approach
        2. 2.2.6.2 Top-Down Approach
      7. 2.2.7 Data Triangulation
      8. 2.2.8 Validation
  3. 3 SECTION III: QUALITATIVE ANALYSIS
    1. 3.1 MARKET DYNAMICS
      1. 3.1.1 Overview
      2. 3.1.2 Drivers
      3. 3.1.3 Restraints
      4. 3.1.4 Opportunities
    2. 3.2 MARKET FACTOR ANALYSIS
      1. 3.2.1 Value chain Analysis
      2. 3.2.2 Porter's Five Forces Analysis
        1. 3.2.2.1 Bargaining Power of Suppliers
        2. 3.2.2.2 Bargaining Power of Buyers
        3. 3.2.2.3 Threat of New Entrants
        4. 3.2.2.4 Threat of Substitutes
        5. 3.2.2.5 Intensity of Rivalry
      3. 3.2.3 COVID-19 Impact Analysis
        1. 3.2.3.1 Market Impact Analysis
        2. 3.2.3.2 Regional Impact
        3. 3.2.3.3 Opportunity and Threat Analysis
  4. 4 SECTION IV: QUANTITATIVE ANALYSIS
    1. 4.1 Pharmaceutical, BY Type (USD Million)
      1. 4.1.1 Condenser
      2. 4.1.2 Non-Condenser
    2. 4.2 Pharmaceutical, BY Voltage Rating (USD Million)
      1. 4.2.1 15Kv-170Kv
      2. 4.2.2 170Kv-245Kv
      3. 4.2.3 245Kv & above
    3. 4.3 Pharmaceutical, BY Installation (USD Million)
      1. 4.3.1 Indoor
      2. 4.3.2 Outdoor
    4. 4.4 Pharmaceutical, BY End-Use Industry (USD Million)
      1. 4.4.1 Industrial
      2. 4.4.2 Utilities
      3. 4.4.3 Others
  5. 5 SECTION V: COMPETITIVE ANALYSIS
    1. 5.1 Competitive Landscape
      1. 5.1.1 Overview
      2. 5.1.2 Competitive Analysis
      3. 5.1.3 Market share Analysis
      4. 5.1.4 Major Growth Strategy in the Pharmaceutical
      5. 5.1.5 Competitive Benchmarking
      6. 5.1.6 Leading Players in Terms of Number of Developments in the Pharmaceutical
      7. 5.1.7 Key developments and growth strategies
        1. 5.1.7.1 New Product Launch/Service Deployment
        2. 5.1.7.2 Merger & Acquisitions
        3. 5.1.7.3 Joint Ventures
      8. 5.1.8 Major Players Financial Matrix
        1. 5.1.8.1 Sales and Operating Income
        2. 5.1.8.2 Major Players R&D Expenditure. 2023
    2. 5.2 Company Profiles
      1. 5.2.1 Siemens (DE)
        1. 5.2.1.1 Financial Overview
        2. 5.2.1.2 Products Offered
        3. 5.2.1.3 Key Developments
        4. 5.2.1.4 SWOT Analysis
        5. 5.2.1.5 Key Strategies
      2. 5.2.2 General Electric (US)
        1. 5.2.2.1 Financial Overview
        2. 5.2.2.2 Products Offered
        3. 5.2.2.3 Key Developments
        4. 5.2.2.4 SWOT Analysis
        5. 5.2.2.5 Key Strategies
      3. 5.2.3 Schneider Electric (FR)
        1. 5.2.3.1 Financial Overview
        2. 5.2.3.2 Products Offered
        3. 5.2.3.3 Key Developments
        4. 5.2.3.4 SWOT Analysis
        5. 5.2.3.5 Key Strategies
      4. 5.2.4 ABB (CH)
        1. 5.2.4.1 Financial Overview
        2. 5.2.4.2 Products Offered
        3. 5.2.4.3 Key Developments
        4. 5.2.4.4 SWOT Analysis
        5. 5.2.4.5 Key Strategies
      5. 5.2.5 Mitsubishi Electric (JP)
        1. 5.2.5.1 Financial Overview
        2. 5.2.5.2 Products Offered
        3. 5.2.5.3 Key Developments
        4. 5.2.5.4 SWOT Analysis
        5. 5.2.5.5 Key Strategies
      6. 5.2.6 Nexans (FR)
        1. 5.2.6.1 Financial Overview
        2. 5.2.6.2 Products Offered
        3. 5.2.6.3 Key Developments
        4. 5.2.6.4 SWOT Analysis
        5. 5.2.6.5 Key Strategies
      7. 5.2.7 Eaton (IE)
        1. 5.2.7.1 Financial Overview
        2. 5.2.7.2 Products Offered
        3. 5.2.7.3 Key Developments
        4. 5.2.7.4 SWOT Analysis
        5. 5.2.7.5 Key Strategies
      8. 5.2.8 Toshiba (JP)
        1. 5.2.8.1 Financial Overview
        2. 5.2.8.2 Products Offered
        3. 5.2.8.3 Key Developments
        4. 5.2.8.4 SWOT Analysis
        5. 5.2.8.5 Key Strategies
      9. 5.2.9 Crompton Greaves (IN)
        1. 5.2.9.1 Financial Overview
        2. 5.2.9.2 Products Offered
        3. 5.2.9.3 Key Developments
        4. 5.2.9.4 SWOT Analysis
        5. 5.2.9.5 Key Strategies
    3. 5.3 Appendix
      1. 5.3.1 References
      2. 5.3.2 Related Reports
  6. 6 LIST OF FIGURES
    1. 6.1 MARKET SYNOPSIS
    2. 6.2 US MARKET ANALYSIS BY TYPE
    3. 6.3 US MARKET ANALYSIS BY VOLTAGE RATING
    4. 6.4 US MARKET ANALYSIS BY INSTALLATION
    5. 6.5 US MARKET ANALYSIS BY END-USE INDUSTRY
    6. 6.6 KEY BUYING CRITERIA OF PHARMACEUTICAL
    7. 6.7 RESEARCH PROCESS OF MRFR
    8. 6.8 DRO ANALYSIS OF PHARMACEUTICAL
    9. 6.9 DRIVERS IMPACT ANALYSIS: PHARMACEUTICAL
    10. 6.10 RESTRAINTS IMPACT ANALYSIS: PHARMACEUTICAL
    11. 6.11 SUPPLY / VALUE CHAIN: PHARMACEUTICAL
    12. 6.12 PHARMACEUTICAL, BY TYPE, 2024 (% SHARE)
    13. 6.13 PHARMACEUTICAL, BY TYPE, 2024 TO 2035 (USD Million)
    14. 6.14 PHARMACEUTICAL, BY VOLTAGE RATING, 2024 (% SHARE)
    15. 6.15 PHARMACEUTICAL, BY VOLTAGE RATING, 2024 TO 2035 (USD Million)
    16. 6.16 PHARMACEUTICAL, BY INSTALLATION, 2024 (% SHARE)
    17. 6.17 PHARMACEUTICAL, BY INSTALLATION, 2024 TO 2035 (USD Million)
    18. 6.18 PHARMACEUTICAL, BY END-USE INDUSTRY, 2024 (% SHARE)
    19. 6.19 PHARMACEUTICAL, BY END-USE INDUSTRY, 2024 TO 2035 (USD Million)
    20. 6.20 BENCHMARKING OF MAJOR COMPETITORS
  7. 7 LIST OF TABLES
    1. 7.1 LIST OF ASSUMPTIONS
  8. 7.1.1
    1. 7.2 US MARKET SIZE ESTIMATES; FORECAST
      1. 7.2.1 BY TYPE, 2025-2035 (USD Million)
      2. 7.2.2 BY VOLTAGE RATING, 2025-2035 (USD Million)
      3. 7.2.3 BY INSTALLATION, 2025-2035 (USD Million)
      4. 7.2.4 BY END-USE INDUSTRY, 2025-2035 (USD Million)
    2. 7.3 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
  9. 7.3.1
    1. 7.4 ACQUISITION/PARTNERSHIP
  10. 7.4.1

US HV Bushing Market Segmentation

US HV Bushing Market By Type (USD Million, 2025-2035)

  • Condenser
  • Non-Condenser

US HV Bushing Market By Voltage Rating (USD Million, 2025-2035)

  • 15Kv-170Kv
  • 170Kv-245Kv
  • 245Kv & above

US HV Bushing Market By Installation (USD Million, 2025-2035)

  • Indoor
  • Outdoor

US HV Bushing Market By End-Use Industry (USD Million, 2025-2035)

  • Industrial
  • Utilities
  • Others
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.